ITRM Stock Analysis: Buy, Sell, or Hold?
ITRM - Iterum Therapeutics plc Ordinary Share
$0.03
-0.04 (-57.39%)
▼
5d:
-82.12%
30d:
-89.38%
90d:
-89.62%
WAIT
LOW Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: Mar 12, 2026
0d
Get Alerted When ITRM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ITRM is down 82.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ITRM is down 82.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ITRM is currently trading at $0.03, which is considered fair based on recent price action.
Technical Outlook: Technically, ITRM is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 57.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+29900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ITRM is in a strong downtrend. Immediate support is located at $0.03, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 57.4% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.00 (+29900.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
43/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-57.4%)
- BULLISH: Trading 29900.0% below Wall St target ($9.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.03
Resistance Level
$0.18
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.10
Wall Street Target
$9.00
(+29900.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 15, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ITRM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1086 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 47 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 27 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 53 HOLD |
